Unconfigured Ad

Collapse

Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc

Forums Topics Posts Last Post
No forums found.
  •  
  • Time
  • Answered
  • Show
  • New Topics
Clear All
new posts
There are no conversations in this channel.
 
  • Time
  • Show
Clear All
new posts
Please log in to your account to view your subscribed posts.
  •  
  • Time
  • Answered
  • Show
  • Sort By
  • Order
Clear All
new posts
Topics Statistics Last Post
Started by laura, 05-09-2011, 04:42 AM
35 responses
108,204 views
0 reactions
Last Post laura
by laura
 
Started by sci_guy, 01-23-2008, 11:19 PM
236 responses
689,207 views
1 reaction
Last Post ECO
by ECO
 
Started by pingu, 10-29-2015, 03:29 AM
3 responses
1,845 views
0 reactions
Last Post cmccabe
by cmccabe
 
Started by shurjo, 10-29-2015, 09:25 AM
0 responses
3,976 views
0 reactions
Last Post shurjo
by shurjo
 
Started by uloeber, 10-26-2015, 09:29 AM
1 response
1,488 views
0 reactions
Last Post uloeber
by uloeber
 
Started by gene_x, 02-19-2013, 09:19 PM
10 responses
5,723 views
0 reactions
Last Post rory
by rory
 
Started by [email protected], 10-29-2015, 06:22 AM
1 response
1,603 views
0 reactions
Last Post dpryan
by dpryan
 
Started by Simon Anders, 04-22-2010, 05:10 AM
191 responses
89,567 views
0 reactions
Last Post Simon Anders  
Started by Marcela Uliano, 10-19-2015, 04:23 AM
4 responses
3,667 views
0 reactions
Last Post Marcela Uliano  
Started by tellsparck, 10-28-2015, 09:01 PM
0 responses
1,558 views
0 reactions
Last Post tellsparck  
Started by Lyn Hsiong, 12-22-2012, 07:19 PM
4 responses
3,179 views
0 reactions
Last Post 4urelie
by 4urelie
 
Started by Morgane_AUS, 10-26-2015, 04:27 PM
6 responses
5,012 views
0 reactions
Last Post Morgane_AUS  
No topics found.
  • Time
Clear All
No photos found.
  • Time
Clear All

Webinars

Collapse

Recent Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM
  • SEQadmin2
    How Immunogenomics Decodes Immunity’s Genetic Blueprint
    by SEQadmin2




    The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.

    This convergence of genetics, immunology, and computation...
    09-01-2026, 05:41 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
17 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Working...